HMGB1 and colorectal carcinoma: CRC patients aged ≥ 60 years (27.7%, 73/264) had a higher positive cytoplasmic HMGB1 rate than patients aged < 60 years (19.0%, 20/105), but the between-group difference was not significant (P = 0.086).